Changeflow GovPing Pharma & Drug Safety USPTO Patent US12583820B2: Antivirals against c...
Routine Notice Added Final

USPTO Patent US12583820B2: Antivirals against coronavirus

Favicon for changeflow.com ChangeBridge: Patent Grants - Organic Chemistry (C07D)
Published March 24th, 2026
Detected March 24th, 2026
Email

Summary

The USPTO has granted patent US12583820B2 to Kansas State University Research Foundation for broad spectrum antivirals against coronaviruses. The patent covers specific chemical compounds designed to inhibit viral replication.

What changed

The United States Patent and Trademark Office (USPTO) has granted patent US12583820B2, assigned to Kansas State University Research Foundation. This patent covers novel compounds exhibiting antiviral activity against viruses, particularly coronaviruses, and includes specific chemical formulas and classifications related to organic chemistry (C07D).

This patent grant represents a new intellectual property asset for Kansas State University Research Foundation. While patents do not impose direct regulatory obligations on other entities, they can influence market exclusivity and licensing opportunities for pharmaceutical and drug manufacturers developing antiviral therapies. Compliance officers should note this as a development in the intellectual property landscape relevant to coronavirus treatments.

Source document (simplified)

← USPTO Patent Grants

Broad spectrum antivirals against coronavirus

Grant US12583820B2 Kind: B2 Mar 24, 2026

Assignee

Kansas State University Research Foundation

Inventors

Kyeong-Ok Chang, Yunjeong Kim, William C. Groutas, Stanley Perlman

Abstract

Compounds exhibiting antiviral activity and/or inhibition of viral replication against viruses, particularly those belonging to the picornavirus-like supercluster, including coronavirus having a formula: (I) where X comprises a cyclic moiety, R2 is a branched or unbranched alkyl, cycloalkyl, aryl, arylalkyl, alkenyl, alkynyl, amino acid side chain, bicyclic or tricyclic side chain, combinations, and substituted forms thereof, and Z is selected from the group consisting of C1-C6 hydroxyalkyl, aldehydes, alpha-ketoamides, and bisulfite salts, and in particular —CH2OH, —CHO, —CH(0H)S03−Na+, and -[0(C=0)Rw]S03−Na+.

CPC Classifications

C07D 207/26

Filing Date

2021-03-30

Application No.

17907745

Claims

12

View original document →

Named provisions

Abstract Claims

Classification

Agency
USPTO
Published
March 24th, 2026
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
US12583820B2

Who this affects

Applies to
Drug manufacturers Pharmaceutical companies
Industry sector
3254 Pharmaceutical Manufacturing
Activity scope
Drug Development Antiviral Research
Geographic scope
United States US

Taxonomy

Primary area
Pharmaceuticals
Operational domain
Research & Development
Topics
Intellectual Property Public Health

Get Pharma & Drug Safety alerts

Weekly digest. AI-summarized, no noise.

Free. Unsubscribe anytime.

Get alerts for this source

We'll email you when ChangeBridge: Patent Grants - Organic Chemistry (C07D) publishes new changes.

Free. Unsubscribe anytime.